1,024
Views
60
CrossRef citations to date
0
Altmetric
Theme: ADHD - Review

The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairs

&
Pages 1107-1116 | Published online: 09 Jan 2014

References

  • Roenneberg T, Kuehnle T, Juda M et al. Epidemiology of the human circadian clock. Sleep Med. Rev. 11(6), 429–438 (2007).
  • Lewy AJ. Melatonin and human chronobiology. Cold Spring Harb. Symp. Quant. Biol. 72, 623–636 (2007).
  • Zavada A, Gordijn MC, Beersma DG, Daan S, Roenneberg T. Comparison of the munich chronotype questionnaire with the Horne–Ostberg's morningness-eveningness score. Chronobiol. Int. 22(2), 267–278 (2005).
  • Roenneberg T, Wirz-Justice A, Merrow M. Life between clocks: daily temporal patterns of human chronotypes. J. Biol. Rhythms 18(1), 80–90 (2003).
  • Brown SA, Kunz D, Dumas A et al. Molecular insights into human daily behavior. Proc. Natl Acad. Sci. USA 105(5), 1602–1607 (2008).
  • Paine SJ, Gander PH, Travier N. The epidemiology of morningness/eveningness: influence of age, gender, ethnicity, and socioeconomic factors in adults (30–49 years). J. Biol. Rhythms 21(1), 68–76 (2006).
  • Roenneberg T, Kuehnle T, Pramstaller PP et al. A marker for the end of adolescence. Curr. Biol. 14(24), R1038–1039 (2004).
  • Taillard J, Philip P, Chastang JF, Bioulac B. Validation of Horne and Ostberg morningness-eveningness questionnaire in a middle-aged population of French workers. J. Biol. Rhythms 19(1), 76–86 (2004).
  • Bijlenga D, van der Heijden KB, Breuk M et al. Associations between sleep characteristics, seasonal depressive symptoms, lifestyle, and ADHD symptoms in adults. J. Atten. Disord. 17(3), 261–274 (2013).
  • Dagan Y. Circadian rhythm sleep disorders (CRSD). Sleep Med. Rev. 6(1), 45–54 (2002).
  • Lee HJ, Rex KM, Nievergelt CM, Kelsoe JR, Kripke DF. Delayed sleep phase syndrome is related to seasonal affective disorder. J. Affect Disord. 133(3), 573–579 (2011).
  • Giglio LM, Magalhaes PV, Andersen ML, Walz JC, Jakobson L, Kapczinski F. Circadian preference in bipolar disorder. Sleep Breath 14(2), 153–155 (2010).
  • Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. Sleep and circadian rhythm disruption in schizophrenia. Br. J. Psychiatry 200(4), 308–316 (2012).
  • Giannotti F, Cortesi F, Sebastiani T, Ottaviano S. Circadian preference, sleep and daytime behaviour in adolescence. J. Sleep Res. 11(3), 191–199 (2002).
  • Hazama GI, Inoue Y, Kojima K, Ueta T, Nakagome K. The prevalence of probable delayed-sleep-phase syndrome in students from junior high school to university in Tottori, Japan. Tohoku. J. Exp. Med. 216(1), 95–98 (2008).
  • Yazaki M, Shirakawa S, Okawa M, Takahashi K. Demography of sleep disturbances associated with circadian rhythm disorders in Japan. Psychiatry Clin. Neurosci. 53(2), 267–268 (1999).
  • Schrader H, Bovim G, Sand T. The prevalence of delayed and advanced sleep phase syndromes. J. Sleep Res. 2(1), 51–55 (1993).
  • Ando K, Kripke DF, Ancoli-Israel S. Delayed and advanced sleep phase symptoms. Isr. J. Psychiatry Relat. Sci. 39(1), 11–18 (2002).
  • APA. Diagnostic and statistical manual of mental disorders (DSM-IV). American Psychiatric Association, Washington DC, USA (1994).
  • Pandi-Perumal SR, Smits M, Spence W et al. Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 31(1), 1–11 (2007).
  • Lewy AJ, Bauer VK, Ahmed S et al. The human phase response curve (PRC) to melatonin is about 12 h out of phase with the PRC to light. Chronobiol. Int. 15(1), 71–83 (1998).
  • Lewy AJ. Circadian misalignment in mood disturbances. Curr. Psychiatry Rep. 11(6), 459–465 (2009).
  • Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J. Clin. Psychiatry 59( Suppl. 7), 4–16 (1998).
  • Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2(2), 104–113 (2003).
  • Fayyad J, De Graaf R, Kessler R et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br. J. Psychiatry 190, 402–409 (2007).
  • Corkum P, Tannock R, Moldofsky H, Hogg-Johnson S, Humphries T. Actigraphy and parental ratings of sleep in children with attention- deficit/hyperactivity disorder (ADHD). Sleep 24(3), 303–312 (2001).
  • Gaultney JF, Terrell DF, Gingras JL. Parent-Reported Periodic Limb Movement, Sleep Disordered Breathing, Bedtime Resistance Behaviors, and ADHD. Behav. Sleep Med. 3(1), 32–43 (2005).
  • Konofal E, Lecendreux M, Bouvard MP, Mouren-Simeoni MC. High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin. Neurosci. 55(2), 97–103 (2001).
  • Lecendreux M, Cortese S. Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future. Expert Rev. Neurother. 7(12), 1799–1806 (2007).
  • Sadeh A, Pergamin L, Bar-Haim Y. Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies. Sleep Med. Rev. 10(6), 381–398 (2006).
  • Yoon SYR, Jain U, Shapiro C. Sleep in attention-deficit/hyperactivity disorder in children and adults: past, present, and future. Sleep Med. Rev. 16(4), 371–388 (2012).
  • Wiebe S, Carrier J, Frenette S, Gruber R. Sleep and sleepiness in children with attention deficit/hyperactivity disorder and controls. J. Sleep Res. 22(1), 41–49. (2013).
  • Scott N, Blair PS, Emond AM et al. Sleep patterns in children with ADHD: a population-based cohort study from birth to 11 years. J. Sleep Res. 22(2), 121–128 (2013).
  • van der Heijden KB, Smits MG, Gunning WB. Sleep-related disorders in ADHD: a review. Clin. Pediatr. (Phila.) 44(3), 201–210 (2005).
  • van der Heijden KB, Smits MG, Van Someren EJ, Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol. Int. 22(3), 559–570 (2005).
  • Van Veen MM, Kooij JJS, Boonstra AM, Gordijn MC, Van Someren EJ. Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol. Psychiatry 67(11), 1091–1096 (2010).
  • Kooij JJS, Middelkoop HA, van Gils K, Buitelaar JK. The effect of stimulants on nocturnal motor activity and sleep quality in adults with ADHD: An open-label case-control study. J. Clin. Psychiatry 62(12), 952–956 (2001).
  • Schredl M, Alm B, Sobanski E. Sleep quality in adult patients with attention deficit hyperactivity disorder (ADHD). Eur. Arch. Psychiatry Clin. Neurosci. 257(3), 164–168 (2007).
  • Shirayama M, Shirayama Y, Iida H et al. The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med. 4(5), 427–433 (2003).
  • Novakova M, Paclt I, Ptacek R, Kuzelova H, Hajek I, Sumova A. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Chronobiol. Int. 28(7), 630–637 (2011).
  • Mahajan N, Hong N, Wigal TL, Gehricke J-G. Hyperactive-impulsive symptoms associated with self-reported sleep quality in nonmedicated adults with ADHD. J. Atten. Disord. 14(2), 132–137 (2010).
  • Gau SS, Kessler RC, Tseng WL et al. Association between sleep problems and symptoms of attention-deficit/hyperactivity disorder in young adults. Sleep 30(2), 195–201 (2007).
  • Antle MC, van Diepen HC, Deboer T, Pedram P, Pereira RR, Meijer JH. Methylphenidate modifies the motion of the circadian clock. Neuropsychopharmacology 37(11), 2446–2455 (2012).
  • Corkum P, Panton R, Ironside S, Macpherson M, Williams T. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J. Pediatr. Psychol. 33(4), 368–379 (2007).
  • Galland BC, Tripp EG, Taylor BJ. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: A matched case-control study. J. Sleep Res. 19(2), 366–373 (2010).
  • Lee SH, Seox WS, Sung HM et al. Effect of methylphenidate on sleep parameters in children with ADHD. Psychiatry Invest. 9(4), 384–390 (2012).
  • Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Pediatrics 96(2 Pt 1), 320–325 (1995).
  • Kim HW, Yoon IY, Cho SC et al. The effect of OROS methylphenidate on the sleep of children with attention-deficit/hyperactivity disorder. Int. Clin. Psychopharmacol. 25(2), 107–115 (2010).
  • Boonstra AM, Kooij JJS, Oosterlaan J, Sergeant JA, Buitelaar JK, Van Someren EJW. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 30(4), 433–442 (2007).
  • Sobanski E, Schredl M, Kettler N, Alm B. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 31(3), 375–381 (2008).
  • Stratmann M, Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J. Biol. Rhythms 21(6), 494–506 (2006).
  • Baird AL, Coogan AN, Siddiqui A, Donev RM, Thome J. Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels. Mol. Psychiatry 17(10), 988–995 (2012).
  • Bijlenga D, Van Someren EJ, Gruber R et al. Body temperature, activity, and melatonin profiles in adults with attention-deficit/hyperactivity syndrome and delayed sleep: a case-control study J. Sleep Res. doi:10.1111/jsr.12075 (2013) ( Epub ahead of print).
  • Cortese S, Bernardina BD, Mouren MC. Attention-deficit/hyperactivity disorder (ADHD) and binge eating. Nutr. Rev. 65(9), 404–411 (2007).
  • Qin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T. The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci. 73(19), 2467–2475 (2003).
  • Spiegel K, Leproult R, L'Hermite-Baleriaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J. Clin. Endocrinol. Metab. 89(11), 5762–5771 (2004).
  • Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent. Psychopharmacol. 6(6), 341–347 (2005).
  • Cappuccio FP, Taggart FM, Kandala NB et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 31(5), 619–626 (2008).
  • Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res. 66(10), 5521–5525 (2006).
  • Schernhammer ES, Berrino F, Krogh V et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J. Natl Cancer Inst. 100(12), 898–905 (2008).
  • Viswanathan AN, Schernhammer ES. Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett. 281(1), 1–7 (2009).
  • Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann. NY Acad. Sci. 1129, 287–304 (2008).
  • Gangwisch JE. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes. Rev. 10( Suppl. 2), 37–45 (2009).
  • Fonken LK, Workman JL, Walton JC et al. Light at night increases body mass by shifting the time of food intake. Proc. Natl Acad. Sci. USA 107(43), 18664–18669 (2010).
  • Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med. Rev. 13(4), 257–264 (2009).
  • Puttonen S, Harma M, Hublin C. Shift work and cardiovascular disease – pathways from circadian stress to morbidity. Scand. J. Work Environ. Health 36(2), 96–108 (2010).
  • Lauderdale DS, Knutson KL, Rathouz PJ, Yan LL, Hulley SB, Liu K. Cross-sectional and longitudinal associations between objectively measured sleep duration and body mass index: the CARDIA Sleep Study. Am. J. Epidemiol. 170(7), 805–813 (2009).
  • Fuemmeler BF, Ostbye T, Yang C, McClernon FJ, Kollins SH. Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study. Int. J. Obes. (Lond.) 35(6), 852–862 (2010).
  • Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2(1), 9 (2002).
  • Fleming JP, Levy LD, Levitan RD. Symptoms of attention deficit hyperactivity disorder in severely obese women. Eat. Weight Disord. 10(1) e10–e13 (2005).
  • Cortese S, Angriman M, Maffeis C et al. Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Crit. Rev. Food Sci. Nutrit. 48(6), 524–537 (2008).
  • Campbell BC, Eisenberg D. Obesity, attention deficit-hyperactivity disorder and the dopaminergic reward system. Coll. Antrop. 31(1), 33–38 (2007).
  • Liu LL, Li BM, Yang J, Wang YW. Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD? Med. Hypotheses 70(6), 1118–1120 (2008).
  • Kakizaki M, Kuriyama S, Sone T et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br. J. Cancer 99(9), 1502–1505 (2008).
  • Stevens RG, Hansen J, Costa G et al. Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report. Occup. Environ. Med. 68(2), 154–162 (2011).
  • Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J. Pineal. Res. 40(2), 116–124 (2006).
  • Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol. Biomarkers Prev. 13(6), 936–943 (2004).
  • Parent ME, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J. Night work and the risk of cancer among men. Am. J. Epidemiol. 176(9), 751–759 (2012).
  • Sigurdardottir LG, Valdimarsdottir UA, Fall K et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol. Biomarkers Prev. 21(7), 1002–1011 (2012).
  • Dopfel RP, Schulmeister K, Schernhammer ES. Nutritional and lifestyle correlates of the cancer-protective hormone melatonin. Cancer Detect. Prev. 31(2), 140–148 (2007).
  • Sliwinski T, Rozej W, Morawiec-Bajda A, Morawiec Z, Reiter R, Blasiak J. Protective action of melatonin against oxidative DNA damage: chemical inactivation versus base-excision repair. Mutat. Res. 634(1–2), 220–227 (2007).
  • Liu R, Fu A, Hoffman AE, Zheng T, Zhu Y. Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways. BMC Cell Biol. 14, 1 (2013).
  • Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Total visual blindness is protective against breast cancer. Cancer Causes Control 20(9), 1753–1756 (2009).
  • Anisimov VN, Vinogradova IA, Panchenko AV, Popovich IG, Zabezhinski MA. Light-at-night-induced circadian disruption, cancer, and aging. Curr. Aging Sci. 5(3), 170–177 (2012).
  • Bonde JP, Hansen J, Kolstad HA et al. Work at night and breast cancer – report on evidence-based options for preventive actions. Scand. J. Work Environ. Health 38(4), 380–390 (2012).
  • Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26(7), 1241–1246 (2005).
  • Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol. Med. 18, 1249–1260 (2012).
  • Jones CR, Huang AL, Ptacek LJ, Fu YH. Genetic basis of human circadian rhythm disorders. Exp. Neurol. 243, 28–33 (2012).
  • Allebrandt KV, Teder-Laving M, Akyol M et al. CLOCK gene variants associate with sleep duration in two independent populations. Biol. Psychiatry 67(11), 1040–1047 (2010).
  • Archer SN, Robilliard DL, Skene DJ et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26(4), 413–415 (2003).
  • Hida A, Kitamura S, Mishima K. Pathophysiology and pathogenesis of circadian rhythm sleep disorders. J. Physiol. Anthropol. 31(1), 7 (2012).
  • Robilliard DL, Archer SN, Arendt J et al. The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects. J. Sleep Res. 11(4), 305–312 (2002).
  • Osland TM, Bjorvatn BR, Steen VM, Pallesen S. Association study of a variable-number tandem repeat polymorphism in the clock gene PERIOD3 and chronotype in Norwegian university students. Chronobiol. Int. 28(9), 764–770 (2011).
  • Xu X, Breen G, Chen CK, Huang YS, Wu YY, Asherson P. Association study between a polymorphism at the 3′-untranslated region of CLOCK gene and attention deficit hyperactivity disorder. Behav. Brain Funct. 6, 48 (2010).
  • Benedetti F, Serretti A, Colombo C et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123B(1), 23–26 (2003).
  • Chen PH, Kuo HY, Chueh KH. Sleep hygiene education: efficacy on sleep quality in working women. J. Nurs. Res. 18(4), 283–289 (2010).
  • Boivin DB, Boudreau P, Tremblay GM. Phototherapy and orange-tinted goggles for night-shift adaptation of police officers on patrol. Chronobiol. Int. 29(5), 629–640 (2012).
  • Romeijn N, Raymann RJ, Most E et al. Sleep, vigilance, and thermosensitivity. Pflugers Arch. 463(1), 169–176 (2012).
  • Ronkainen H, Vakkuri O, Kauppila A. Effects of physical exercise on the serum concentration of melatonin in female runners. Acta Obstet. Gynecol. Scand. 65(8), 827–829 (1986).
  • van der Heijden KB, Smits MG, Van Someren EJW, Ridderinkhof KR, Gunning WB. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J. Am. Acad. Child Adol. Psychiatry 46(2), 233–241 (2007).
  • Lewy AJ, Emens JS, Lefler BJ, Yuhas K, Jackman AR. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol. Int. 22(6), 1093–1106 (2005).
  • van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep 33(12), 1605–1614 (2010).
  • Carrillo-Vico A, Reiter RJ, Lardone PJ et al. The modulatory role of melatonin on immune responsiveness. Curr. Opin. Invest. Drugs 7(5), 423–431 (2006).
  • Lewy AJ, Rough JN, Songer JB, Mishra N, Yuhas K, Emens JS. The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin. Neurosci. 9(3), 291–300 (2007).
  • Crowley SJ, Eastman CI. Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance. Psychopharmacology (Berl.) 225(4), 825–837 (2012)..
  • Arns M, van der Heijden KB, Arnold LE, Kenemans JL. Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol. Psychiatry 74(8), 585–590 (2013).
  • Rosenthal NE, Joseph-Vanderpool JR, Levendosky AA et al. Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep 13(4), 354–361 (1990).
  • Paul MA, Gray GW, Lieberman HR et al. Phase advance with separate and combined melatonin and light treatment. Psychopharmacology (Berl.) 214(2), 515–523 (2011).
  • Kooij JJS. Adult ADHD: Diagnostic Assessment and Treatment. Springer, London (2013).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.